Health CareHealth Care Equipment & Services
  • Price (GBX)1,527.50
  • Today's Change1.50 / 0.10%
  • Shares traded404.82k
  • 1 Year change+0.13%
  • Beta0.7350
Data delayed at least 20 minutes, as of May 17 2021 13:26 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade, Smith & Nephew PLC (SN.:LSE) traded at 1,527.50, 15.98% above the 52 week low of 1,317.00 set on Nov 02, 2020.
52-week range
1,317.00Nov 02 20201,742.50Jun 04 2020
Markit short selling activity
Previous close1,526.00
Average volume2.01m
Shares outstanding879.04m
Free float876.67m
P/E (TTM)42.10
Market cap13.41bn GBP
EPS (TTM)0.3625
Annual div (ADY)27.69
Annual div yield (ADY)1.81%
Div ex-dateApr 01 2021
Div pay-dateMay 12 2021
Data delayed at least 20 minutes, as of May 17 2021 13:26 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Smith & Nephew PLC shares was Buy at 1,492.00 on 18 Feb 2021Read the full article
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.